fda tirzepatide news Officially Removes from Shortage: Is This The End of Zepbound and Mounjaro Copies? FDA shakes up weight loss

Both companies have built extensive patent thickets around their core molecules, with Novo Nordisk in particular pursuing aggressive filing strategies across new formulations, indications, and delivery methods

A study on liraglutide and PCOS showed that the medication helped improve ovulation rates and reproductive hormone levels in women with the condition

A mismatch between the submitted diagnosis and the product's approved indication is the most frequent cause, followed by missing chart documentation such as recorded BMI over time or a documented weight-related comorbid condition

A Herx reaction may also amplify mast cell activation, leading to MCAS flare-ups

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND

Misusing these products is illegal